vs
IDEAYA Biosciences, Inc.（IDYA）与MATTHEWS INTERNATIONAL CORP（MATW）财务数据对比。点击上方公司名可切换其他公司
MATTHEWS INTERNATIONAL CORP的季度营收约是IDEAYA Biosciences, Inc.的1.4倍（$284.8M vs $207.8M），IDEAYA Biosciences, Inc.净利率更高（57.4% vs 15.3%，领先42.1%），IDEAYA Biosciences, Inc.自由现金流更多（$142.2M vs $-57.2M）
IDEAYA Biosciences是一家临床阶段生物技术企业，专注于肿瘤学领域，研发针对基因定义癌症的靶向疗法及合成致死治疗方案，推进多肿瘤类型的候选药物管线开发，与行业伙伴合作提升全球创新癌症治疗方案的可及性。
马修斯国际旗下的马修斯奥罗拉殡葬解决方案公司是美国规模最大的棺材与骨灰瓮生产商之一，2005年的数据显示其棺材产品占据美国市场超38%的份额，总部位于印第安纳州奥罗拉。该公司同时生产木质、金属棺材与骨灰瓮产品，也为殡葬机构提供殡葬用品供应与咨询服务。
IDYA vs MATW — 直观对比
营收规模更大
MATW
是对方的1.4倍
$207.8M
净利率更高
IDYA
高出42.1%
15.3%
自由现金流更多
IDYA
多$199.4M
$-57.2M
损益表 — Q3 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $207.8M | $284.8M |
| 净利润 | $119.2M | $43.6M |
| 毛利率 | — | 35.0% |
| 营业利润率 | 52.2% | 34.2% |
| 净利率 | 57.4% | 15.3% |
| 营收同比 | — | -29.1% |
| 净利润同比 | 330.1% | 1356.6% |
| 每股收益（稀释后） | $1.33 | $1.39 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收IDYAMATW
| Q4 25 | — | $284.8M | ||
| Q3 25 | $207.8M | — | ||
| Q3 24 | $0 | — | ||
| Q2 24 | $0 | — | ||
| Q1 24 | $0 | — | ||
| Q3 22 | $29.7M | — |
净利润IDYAMATW
| Q4 25 | — | $43.6M | ||
| Q3 25 | $119.2M | — | ||
| Q3 24 | $-51.8M | — | ||
| Q2 24 | $-52.8M | — | ||
| Q1 24 | $-39.6M | — | ||
| Q3 22 | $1.6M | — |
毛利率IDYAMATW
| Q4 25 | — | 35.0% | ||
| Q3 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q3 22 | — | — |
营业利润率IDYAMATW
| Q4 25 | — | 34.2% | ||
| Q3 25 | 52.2% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q3 22 | 2.2% | — |
净利率IDYAMATW
| Q4 25 | — | 15.3% | ||
| Q3 25 | 57.4% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q3 22 | 5.4% | — |
每股收益（稀释后）IDYAMATW
| Q4 25 | — | $1.39 | ||
| Q3 25 | $1.33 | — | ||
| Q3 24 | $-0.60 | — | ||
| Q2 24 | $-0.68 | — | ||
| Q1 24 | $-0.53 | — | ||
| Q3 22 | $0.04 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $786.9M | $31.4M |
| 总债务越低越好 | — | $529.8M |
| 股东权益账面价值 | $1.1B | $543.2M |
| 总资产 | $1.2B | $1.6B |
| 负债/权益比越低杠杆越低 | — | 0.98× |
8季度趋势，按日历期对齐
现金及短期投资IDYAMATW
| Q4 25 | — | $31.4M | ||
| Q3 25 | $786.9M | — | ||
| Q3 24 | $920.0M | — | ||
| Q2 24 | $701.7M | — | ||
| Q1 24 | $698.8M | — | ||
| Q3 22 | $386.2M | — |
总债务IDYAMATW
| Q4 25 | — | $529.8M | ||
| Q3 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q3 22 | — | — |
股东权益IDYAMATW
| Q4 25 | — | $543.2M | ||
| Q3 25 | $1.1B | — | ||
| Q3 24 | $1.2B | — | ||
| Q2 24 | $931.7M | — | ||
| Q1 24 | $935.3M | — | ||
| Q3 22 | $368.8M | — |
总资产IDYAMATW
| Q4 25 | — | $1.6B | ||
| Q3 25 | $1.2B | — | ||
| Q3 24 | $1.2B | — | ||
| Q2 24 | $973.7M | — | ||
| Q1 24 | $961.5M | — | ||
| Q3 22 | $410.9M | — |
负债/权益比IDYAMATW
| Q4 25 | — | 0.98× | ||
| Q3 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q3 22 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $142.2M | $-52.0M |
| 自由现金流经营现金流 - 资本支出 | $142.2M | $-57.2M |
| 自由现金流率自由现金流/营收 | 68.4% | -20.1% |
| 资本支出强度资本支出/营收 | 0.0% | 1.8% |
| 现金转化率经营现金流/净利润 | 1.19× | -1.19× |
| 过去12个月自由现金流最近4个季度 | $13.5M | — |
8季度趋势，按日历期对齐
经营现金流IDYAMATW
| Q4 25 | — | $-52.0M | ||
| Q3 25 | $142.2M | — | ||
| Q3 24 | $-49.2M | — | ||
| Q2 24 | $-32.9M | — | ||
| Q1 24 | $-43.8M | — | ||
| Q3 22 | $-24.2M | — |
自由现金流IDYAMATW
| Q4 25 | — | $-57.2M | ||
| Q3 25 | $142.2M | — | ||
| Q3 24 | $-49.7M | — | ||
| Q2 24 | $-33.9M | — | ||
| Q1 24 | $-45.1M | — | ||
| Q3 22 | $-25.3M | — |
自由现金流率IDYAMATW
| Q4 25 | — | -20.1% | ||
| Q3 25 | 68.4% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q3 22 | -85.1% | — |
资本支出强度IDYAMATW
| Q4 25 | — | 1.8% | ||
| Q3 25 | 0.0% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q3 22 | 3.7% | — |
现金转化率IDYAMATW
| Q4 25 | — | -1.19× | ||
| Q3 25 | 1.19× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q3 22 | -14.96× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
